However, previously, the study by Nasim et al. (2012) [46] identified several acute phase proteins as potential biomarkers for breast carcinoma but reported that transthyretin was significantly downregulated in the sera of BC patients [46]. This evidence concerns the gene TTR and breast carcinoma.